Business Insights and Analytics

Our Insight team applies rigorous analysis and expert interpretation in order to provide strategic recommendations

Read more

Strategic and Scientific Consulting

Our Consulting team help solve complex scientific and commercial challenges and drive strategy throughout the product lifecycle

Read more

Scientific and Creative Communications

Our Communications team care passionately about the science and making evidence matter across the entire healthcare spectrum

Read more

Business Insights and Analytics

Plus icon

Our Insight team applies rigorous analysis and expert interpretation in order to provide strategic recommendations

Read more

Strategic and Scientific Consulting

Plus icon

Our Consulting team help solve complex scientific and commercial challenges and drive strategy throughout the product lifecycle

Read more

Scientific and Creative Communications

Plus icon

Our Communications team care passionately about the science and making evidence matter across the entire healthcare spectrum

Read more

Why we do what we do

The healthcare industry is going through fundamental change and in this uncertainty our clients need to convert great science into winning strategy

Our clients tell us they need our support in making the right strategic decisions that ensure their products fulfill their potential and ultimately improve people’s lives

We love working at the cutting edge, helping to tackle our clients’ newest and most complex problems

Teams of experts

We are expert navigators helping guide our clients to more successful outcomes

With a global perspective

We work with 24 of the top 25 pharmaceutical companies as well as 100s of biotechs globally from our offices in the US and Europe

Solving unique problems

Whether we are supporting you on your journey, or delivering specialist expertise, we are helping you make important choices

Share our fresh thinking >

Anticancer Cellular Immunotherapies: Optimizing the Path from Bench to FDA Approval
Anticancer Cellular Immunotherapies: Optimizing the Path from Bench to FDA Approval
A striking number of anticancer cellular immunotherapies, also commonly referred to as adoptive cellular therapies (ACT), are in various stages of development, either as monotherapies or in combination with other treatments.
What does patient centricity mean to you?  Q&A with Pharma Progress speaker Ceinwen Giles
What does patient centricity mean to you? Q&A with Pharma Progress speaker Ceinwen Giles
1. What does patient centricity mean to you?Putting the patient “at the centre” of everything that you do sounds relatively easy but, patient centricity is about firmly putting this thought into direct action.
Scientific literacy in a pandemic: can the public really ‘follow the science’?
Scientific literacy in a pandemic: can the public really ‘follow the science’?
When COVID-19 erupted, the world sat up and took notice of a little known and even less understood novel coronavirus. We witnessed the spread of a pandemic, but also an ‘infodemic’ according to the World Health Organisation, and terms such as social distancing, R number, asymptomatic, and ‘flattening the curve’ entered our everyday lexicon.
Future-proofing patient journeys: Detour or new direction?
Future-proofing patient journeys: Detour or new direction?
There is much talk of the old and new normal, but the reality of the future will be a blend of the two, and the patients’ journey with their disease will have a different shape going forward.

Let’s work together

The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today.